Published in Women's Health Weekly, May 22nd, 1995
Preliminary results of this study were made public first at a scientific meeting in 1992 and again a year ago.
In this study, women taking 40 mg of tamoxifen daily for two to five years had a 40 percent decreased risk of cancer in the opposite breast, an almost six-fold increased risk of endometrial cancer, and no increased risk of liver cancer. In addition, the researchers noted a possible increased risk of stomach and colorectal cancers, although...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly